03.12.2012 Views

Clinical Manual for Management of the HIV-Infected ... - myCME.com

Clinical Manual for Management of the HIV-Infected ... - myCME.com

Clinical Manual for Management of the HIV-Infected ... - myCME.com

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Primary <strong>HIV</strong> Infection<br />

Background<br />

Primary <strong>HIV</strong> infection refers to <strong>the</strong> very early stages<br />

<strong>of</strong> <strong>HIV</strong> infection, or <strong>the</strong> interval from initial infection<br />

to <strong>the</strong> time that antibody to <strong>HIV</strong> is detectable. During<br />

this stage <strong>of</strong> <strong>HIV</strong> infection, patients typically have<br />

symptoms <strong>of</strong> acute <strong>HIV</strong> seroconversion illness, very<br />

high <strong>HIV</strong> RNA levels <strong>of</strong> >100,000 copies/mL, and<br />

negative or indeterminate <strong>HIV</strong> antibody tests.<br />

The diagnosis <strong>of</strong> patients with primary <strong>HIV</strong> infection<br />

is a clinical challenge. The symptoms <strong>of</strong> primary <strong>HIV</strong><br />

are nonspecific, and although many patients seek<br />

medical care <strong>for</strong> symptoms <strong>of</strong> <strong>HIV</strong> seroconversion<br />

illness, <strong>the</strong> diagnosis <strong>com</strong>monly is missed at initial<br />

presentation. The difficulties involve recognizing<br />

<strong>the</strong> clinical presentation <strong>of</strong> acute <strong>HIV</strong> infection and<br />

testing patients appropriately. In <strong>HIV</strong> treatment<br />

clinics, clinicians generally do not see patients with<br />

primary <strong>HIV</strong> infection, unless <strong>the</strong>y are referred with<br />

this diagnosis already established. In o<strong>the</strong>r health care<br />

settings, clinicians may not be familiar with <strong>the</strong> signs<br />

and symptoms <strong>of</strong> acute <strong>HIV</strong> infection and <strong>of</strong>ten do not<br />

consider this diagnosis.<br />

After infection with <strong>HIV</strong>, it takes a median <strong>of</strong> 25<br />

days be<strong>for</strong>e <strong>the</strong> <strong>HIV</strong> antibody test be<strong>com</strong>es positive;<br />

in some individuals, it may be several months be<strong>for</strong>e<br />

seroconversion. Individuals with known exposures to<br />

<strong>HIV</strong>, whe<strong>the</strong>r occupational or not, should be monitored<br />

closely beginning at about 3 weeks after exposure<br />

(routine monitoring at 6 weeks, 3 months, and 6<br />

months after exposure to <strong>HIV</strong> is likely to result in<br />

delayed diagnosis <strong>of</strong> <strong>HIV</strong> infection). For in<strong>for</strong>mation on<br />

postexposure prophylaxis, see chapters Nonoccupational<br />

Postexposure Prophylaxis and Occupational Postexposure<br />

Prophylaxis.<br />

S: Subjective<br />

More than three quarters <strong>of</strong> patients who be<strong>com</strong>e<br />

infected with <strong>HIV</strong> develop symptoms consistent with<br />

primary <strong>HIV</strong> infection. Symptoms typically appear<br />

a few days to a few weeks after exposure to <strong>HIV</strong>, and<br />

generally include several <strong>of</strong> <strong>the</strong> following:<br />

♦<br />

♦<br />

♦<br />

Fever<br />

Rash, <strong>of</strong>ten ery<strong>the</strong>matous maculopapular<br />

Fatigue<br />

Section 1—Testing and Assessment | 1–33<br />

♦ Pharyngitis<br />

♦ Generalized lymphadenopathy<br />

♦ Urticaria<br />

♦ Myalgia/arthralgia<br />

♦ Anorexia<br />

♦ Mucocutaneous ulceration<br />

♦ Headache, retroorbital pain<br />

♦<br />

Neurologic symptoms (eg, aseptic meningitis,<br />

radiculitis, myelitis)<br />

This symptomatic phase usually persists <strong>for</strong> 2-4 weeks<br />

or less, although lymphadenopathy may last longer.<br />

These symptoms and signs are similar to those <strong>of</strong> many<br />

o<strong>the</strong>r illnesses, including o<strong>the</strong>r viral syndromes. To<br />

diagnose early <strong>HIV</strong> infection, clinicians must consider<br />

<strong>HIV</strong> in <strong>the</strong> differential diagnosis <strong>for</strong> at-risk patients<br />

with symptoms resembling flu or mononucleosis. A<br />

history <strong>of</strong> recent risk behaviors should be obtained from<br />

all patients who present with symptoms consistent with<br />

acute <strong>HIV</strong> infection.<br />

O: Objective<br />

During <strong>the</strong> symptomatic phase <strong>of</strong> <strong>HIV</strong> seroconversion,<br />

<strong>the</strong> <strong>HIV</strong> antibody test is likely to be negative or<br />

indeterminate. For patients who have symptoms<br />

consistent with seroconversion illness and a recent<br />

high-risk history <strong>for</strong> <strong>HIV</strong> exposure, an <strong>HIV</strong> RNA<br />

(viral load) test should be per<strong>for</strong>med, in addition to <strong>the</strong><br />

<strong>HIV</strong> antibody test, as part <strong>of</strong> <strong>the</strong> evaluation. Patients<br />

with negative antibody tests but high <strong>HIV</strong> viral loads<br />

(>100,000 copies/mL) can be considered to be infected<br />

with <strong>HIV</strong>, although <strong>the</strong> antibody test should be<br />

repeated later to confirm seroconversion. False-positive<br />

<strong>HIV</strong> viral loads have been reported in approximately 5%<br />

<strong>of</strong> patients who were tested after <strong>HIV</strong> exposures. A low<br />

viral load (100,000 copies/mL and <strong>of</strong>ten<br />

millions <strong>of</strong> copies/mL) in acute infection. Patients who<br />

have indeterminate <strong>HIV</strong> antibody test results, low <strong>HIV</strong><br />

viral loads, and no clear <strong>HIV</strong> risk factors or symptoms<br />

<strong>of</strong> primary <strong>HIV</strong> infection should have repeat antibody<br />

testing in 4-6 weeks, without o<strong>the</strong>r interventions. For<br />

patients without significant risk factors, indeterminate<br />

results rarely indicate evolving seroconversion.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!